2022
Circulating T Cells and Cardiovascular Risk in People With and Without HIV Infection
Kundu S, Freiberg MS, Tracy RP, So-Armah KA, Koethe JR, Duncan MS, Tindle HA, Beckman JA, Feinstein MJ, McDonnell WJ, Justice A, Doyle MF, Study V. Circulating T Cells and Cardiovascular Risk in People With and Without HIV Infection. Journal Of The American College Of Cardiology 2022, 80: 1633-1644. PMID: 36265959, DOI: 10.1016/j.jacc.2022.08.756.Peer-Reviewed Original ResearchConceptsT cell subsetsT helper type 17 (Th17) cellsCVD risk factorsIncident CVD eventsType 17 cellsIncident CVDCell subsetsHIV infectionCVD eventsRisk factorsInternational ClassificationT effector memory cellsRe-expressing CD45RAEffector memory cellsSubset of CD4Cardiovascular disease riskProportional hazards regressionT helper cellsMedian participant ageLow CD4Cardiovascular riskObservational cohortPrevalent CVDCVD incidenceRevision diagnosis
2015
HIV Infection, Cardiovascular Disease Risk Factor Profile, and Risk for Acute Myocardial Infarction
Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, Rimland D, Bedimo R, Goetz MB, Rodriguez-Barradas MC, Crane HM, Gibert CL, Brown ST, Tindle HA, Warner AL, Alcorn C, Skanderson M, Justice AC, Freiberg MS. HIV Infection, Cardiovascular Disease Risk Factor Profile, and Risk for Acute Myocardial Infarction. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2015, 68: 209-216. PMID: 25588033, PMCID: PMC4441201, DOI: 10.1097/qai.0000000000000419.Peer-Reviewed Original ResearchConceptsCardiovascular disease risk factorsMajor cardiovascular disease risk factorsAcute myocardial infarctionAMI ratesAMI riskMyocardial infarctionVeterans Aging Cohort Study Virtual CohortCardiovascular disease risk factor profileElevated cardiovascular disease risk factorsTraditional cardiovascular disease risk factorsCardiac healthIncident acute myocardial infarctionRisk of AMIRisk factor profileDisease risk factorsFirst clinical encounterLast followPrevalent CVDHIV infectionRisk factorsFactor profileExclusive profilesVirtual cohortClinical encountersSubstance use